This article is intended for pharmacists and other Australian healthcare professionals. It provides general regulatory information only and is not medical advice, legal advice, or a substitute for the Poisons Standard, TGA guidance, or state/territory legislation. Content should be reviewed against current TGA publications before use, as scheduling and regulatory requirements can change.
Australian pharmacists play an important role in ensuring medicinal cannabis products are supplied safely and in accordance with Australian legislation. Understanding medicinal cannabis scheduling is essential because scheduling determines the legal requirements for prescribing, dispensing, storage and record keeping.
This guide explains the differences between Schedule 4 (S4) and Schedule 8 (S8) medicinal cannabis products, outlines key pharmacist responsibilities, and highlights practical considerations for maintaining compliance with Australian medicinal cannabis regulations.
Medicinal cannabis products are classified under the Poisons Standard according to their cannabinoid composition.
Medicinal cannabis products containing tetrahydrocannabinol (THC) are generally classified as Schedule 8 (Controlled Drugs). These products are subject to additional regulatory controls relating to prescribing, dispensing, storage and record-keeping.
Examples include THC-containing oils, capsules, flower products and other formulations.
Medicinal cannabis products containing predominantly cannabidiol (CBD) — with at least 98% cannabidiol and no more than 2% other cannabinoids, and no other active ingredients — are generally classified as Schedule 4 (Prescription Only Medicines).
Although Schedule 4 products have different regulatory requirements to Schedule 8 medicines, pharmacists must still ensure prescriptions comply with applicable Commonwealth and state or territory legislation.
Understanding medicinal cannabis scheduling helps pharmacists determine the appropriate dispensing process and compliance obligations for each product.
Before dispensing medicinal cannabis, pharmacists should verify that prescriptions meet all applicable legal and professional requirements.
Key checks include:
Because medicinal cannabis products are not generally interchangeable, pharmacists should dispense the exact product prescribed. If the prescribed product is unavailable, the pharmacist should contact the prescriber before making any changes.
Pharmacists have professional responsibilities that extend beyond supplying the medicine. These include:
Pharmacists should also report suspected adverse events through the Therapeutic Goods Administration (TGA) adverse event reporting system where appropriate.
Appropriate storage is an important component of medicinal cannabis pharmacy compliance.
Schedule 8 medicinal cannabis products should be stored in accordance with relevant state or territory controlled medicine requirements, including secure storage with restricted access where required.
Pharmacies should also implement robust inventory management processes, including:
Maintaining current inventory information can also assist pharmacists when communicating with prescribers regarding product availability.
Accurate documentation supports compliance with Australian medicinal cannabis regulations. Depending on the jurisdiction, pharmacists may be required to:
Regular review of dispensing records can also support quality assurance and regulatory compliance.
While regulatory requirements should never be bypassed, pharmacists can improve workflow efficiency by following consistent dispensing processes.
Best practices include:
Clear communication between pharmacists, prescribers and suppliers helps minimise unnecessary administrative delays while supporting compliant dispensing practices.
Can pharmacists dispense medicinal cannabis in Australia? Yes. Pharmacists may dispense medicinal cannabis when prescriptions comply with applicable Commonwealth and state or territory legislation and any required prescribing approvals have been obtained where applicable.
What documentation should pharmacists check? Pharmacists should ensure prescriptions are valid, verify any required approvals where applicable, and confirm that all legislative and professional requirements have been met before dispensing.
Can pharmacists substitute another medicinal cannabis product? Generally, pharmacists should dispense the product prescribed. If an alternative product is required, pharmacists should consult the prescriber and follow applicable legislation before making any changes.
For current scheduling decisions, the Poisons Standard, and TGA guidance on medicinal cannabis, refer to the Therapeutic Goods Administration website (tga.gov.au). Pharmacists should also consult their state or territory health department for jurisdiction-specific requirements around Schedule 8 storage, record-keeping and prescriber approvals.
This page is intended for a healthcare-professional audience. If you are a member of the public seeking information about medicinal cannabis, speak with your doctor or pharmacist, or visit the TGA’s consumer information pages.
“*” indicates required fields
PRIVACY COLLECTION NOTICE
This Privacy Collection Notice describes how PHENIX HEALTH PTY LTD (ABN 22 607 822 266) (we, us or our) collects and handles your personal information when you make an enquiry with us. We collect personal information from you so that we can respond to your enquiry and for related purposes set out in our Privacy Policy, available on our website (or on request).
We may disclose this personal information to third parties, including our personnel, related entities, any third parties engaged by us and acting on our behalf and as otherwise set out in our Privacy Policy.
We store personal information in Australia. Where we disclose your personal information to third parties, those third parties may store, transfer or access personal information outside of Australia.
If you do not provide your personal information to us, it may affect our ability to do business with you.
Please see our Privacy Policy for more information about how we collect, store, use and disclose your personal information, including details about overseas disclosure, access, correction, how you can make a privacy-related complaint and our complaint-handling process.
If you have questions about our privacy practices, please contact us by email at: info@thecompendium.health. By providing your personal information to us, you agree to the collection, use, storage and disclosure of that information as described in this privacy collection notice.
